Health & biomedicine
Diagnostics, therapeutics, regenerative medicine: every page is about what exactly stands between you and a measurement, a cure, or a grown tissue.
The biomedical sector is built around three questions: what is happening in the body, how to change it, and how to verify the change. The clusters answer in order: diagnostics & medtech — measurement inside the body’s noise (affinity windows, Poisson counting, the Bayes arithmetic of screening); therapeutic platforms — delivery and selectivity as the standing trade; regenerative & personalised medicine — growing tissue and fitting therapy to one patient.
The sector’s recurring motif is the price of noise: every measurement in a living body competes with motion, degradation and immunity, and every treatment competes with the body’s drive to restore the status quo. The second motif is time: a diagnostic is worth not its accuracy but whether the answer arrives early enough to act on.
The sector’s entry point is diagnostics biosensors: the transduction and specificity vocabulary the other pages stand on.
Therapeutics & platforms
Delivery is everything and the last step of the journey decides; the process defines the drug; specificity cuts both ways; and the trial, not the pharmacology, …
28 pages
Diagnostics & medtech
Thirty-six subjects on how a measurement earns the right to be believed — from transduced biosensors to organs on chips — and the recurring discovery that the …
36 pages
Regenerative & personalized
The interface decides; a preparation is a population, not a product; and a batch of one is a scientific problem, not a logistics one.
20 pages